Autoimmune hemolytic anemia in children: Clinical presentation and treatment outcome
BACKGROUND: Autoimmune hemolytic anemias (AIHA) are characterized by the destruction of red cells following the production of autoantibodies directed against them. Although AIHA in children is usually self-limiting, many still succumb to the illness due to delay in the diagnosis and treatment. AIHA...
Guardado en:
Autores principales: | Satyam Arora, Seema Dua, Nita Radhakrishnan, Savitri Singh, Jyotsna Madan, Devajit Nath |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer Medknow Publications
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3e58b49f2cca440dbaa785dfe30ed5e6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Blood group discrepancy in mixed-type autoimmune hemolytic anemia in a pediatric patient
por: Minal Wasnik, et al.
Publicado: (2021) -
Bortezomib in autoimmune hemolytic anemia and beyond
por: Raffaella Pasquale, et al.
Publicado: (2021) -
A New Murine Model of Primary Autoimmune Hemolytic Anemia (AIHA)
por: Flavia Dei Zotti, et al.
Publicado: (2021) -
First report of expansion of CD4+/CD28 null T-helper lymphocytes in adult patients with idiopathic autoimmune hemolytic anemia
por: Soha R. Youssef, et al.
Publicado: (2021) -
RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
por: Fatma YILMAZ, et al.
Publicado: (2021)